Skip to content
akaturk Academic measurement
Sign in Sign up

Academician

CENK DAĞLIOĞLU

Doçent

İstanbul Üniversitesi-Cerrahpaşa Cerrahpaşa Tıp Fakültesi Temel Tıp Bilimleri Bölümü

Research topics OpenAlex
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Tıbbi Biyokimya
Articles 15 YÖKSİS 15 · OpenAlex 0 Total citations 380 h-index 8 · OpenAlex OpenAlex coverage %100 matched 15 / 15 Q1 articles 9 Scopus · WoS Q1 5 Best field rank #19,006 / 39,749 Main field · top 47.8% Co-authors 15 3 Turkish institutions

Citation impact

Citation counts of the articles matched in OpenAlex, citing publications from Crossref and the Stanford/Elsevier list. Sources are shown separately and never added up.

OpenAlex YÖKSİS articles matched in OpenAlex: 15
h-index 8 Percentile in Türkiye: 77 #545 of 1,539 at their university by h-index
i10-index
8
Total citations
380
Top 15% in Türkiye
Per article
25.3
FWCI
1.03
1.00 = world average
World top 1%
0
World top 10%
2

Most cited articles

  1. The Role of Cysteine Cathepsins in Cancer Progression and Drug Resistance 2019 world top 10% 158 citations
  2. Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy 2021 world top 10% 71 citations
  3. Enhancing Tumor Cell Response to Multidrug Resistance with pH-Sensitive Quercetin and Doxorubicin Conjugated Multifunctional Nanoparticles 2017 46 citations
How is this computed?

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.

Citing publications Crossref 91 publications citing 15 DOI-bearing articles · 8 Türkiye-affiliated
  • 2019 5
  • 2020 30
  • 2021 31
  • 2022 12
  • 2025 12
  • 2026 1
  1. DOI 10.1016/j.tibs.2025.10.006 2026
  2. NiCo₂O₄ nanoparticles as chemosensitizers: enhancing doxorubicin-ınduced ıntrinsic apoptosis in A549 and MCF-7 cells TR Esra Palabiyik et al. · Naunyn-Schmiedeberg's Archives of Pharmacology · 2025
  3. DOI 10.1007/s11243-025-00697-9 2025
  4. DOI 10.1007/s12032-025-03152-y 2025
  5. DOI 10.3390/jmp6040032 2025
  6. DOI 10.1016/j.ejps.2025.107336 2025
  7. DOI 10.1002/ddr.70185 2025 · cites 2 articles of this academic
  8. DOI 10.1038/s41598-025-20107-5 2025
  9. DOI 10.1134/s0006297925602205 2025
  10. DOI 10.26508/lsa.202503312 2025
  11. DOI 10.3390/biology14111578 2025
  12. DOI 10.1007/s40610-025-00168-1 2025
  13. DOI 10.1007/s12672-025-03810-7 2025
  14. DOI 10.1080/17425247.2022.2047020 2022
  15. DOI 10.2139/ssrn.4017384 2022
  16. DOI 10.1016/j.crgsc.2022.100295 2022
  17. DOI 10.3389/fphar.2022.854506 2022
  18. DOI 10.1039/d2cc01082h 2022
  19. DOI 10.1007/s00018-021-04117-w 2022
  20. DOI 10.1016/j.ijbiomac.2022.03.014 2022
  21. DOI 10.3390/jof8020109 2022
  22. DOI 10.1016/j.pdpdt.2022.102716 2022
  23. DOI 10.1080/09553002.2022.2027540 2022
  24. DOI 10.32604/biocell.2022.019724 2022
  25. DOI 10.3390/ijms23031784 2022
  26. MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity TR Milad Ashrafizadeh et al. · European Journal of Pharmacology · 2021
  27. Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy TR Magdalena Rudzińska et al. · Drug Design, Development and Therapy · 2021 · cites 3 articles of this academic
  28. Anti-microbial and anti-cancer activities of Mn 0.5 Zn 0.5 Dy x Fe 2-x O 4 (x ≤ 0.1) nanoparticles TR Suhailah S. Al-Jameel et al. · Artificial Cells, Nanomedicine, and Biotechnology · 2021
  29. Immobilization and Characterization of Trypsin on TiO2 Nanoparticles Activated with Crosslinkers TR Selmihan ŞAHİN et al. · Academic Platform Journal of Engineering and Science · 2021
  30. DOI 10.1038/s41598-021-93998-9 2021

Showing the 30 most recent.

Where does this list come from?

Extracted from the reference lists in Crossref’s public March 2026 data file; 20.3% of the file has been processed, so the list may be incomplete. Crossref citations are never added to or compared with the OpenAlex citation counts; the two sources have different coverage.

Field ranking

Position in the main-field, side-field and keyword cohorts by YÖKSİS article score; each card opens that ranking.

YÖKSİS ?

Works 15

YÖKSİS and OpenAlex records: index distribution, journals published in, a filterable article list and the other output types.

Indexes and citation percentiles

?
TR Index 2 articles
OpenAlex citation percentile
Top 1%0
Top 10%2
Avg · n 15 %58.3
Other counts

Scopus (SJR)

  • YÖKSİS rows 11

WoS (JCR)

  • YÖKSİS rows 14

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

15articles

Journals with publications

14 journals

Narrow down

Scopus (SJR)
Q19 Q22 Q30 Q40
WoS (JCR)
Q15 Q25 Q30 Q44
TR Index
2articles

Article list

  1. 2025 3-Aminobenzamide-linked Multifunctional Nanoparticles: A Potent Strategy for Modulating PARP1 in Cervical Cancer Cells Cell Biochemistry and Biophysics DOI 10.1007/s12013-025-01813-3 YÖKSİS SJR Q2 JCR Q2 OpenAlex 16.3%
  2. 2025 Characterization of the Potential Cytotoxicity of Klebsiella pneumoniae Isolated from Colorectal Cancer Patients against a Normal Human Fibroblast Model ACS Omega DOI 10.1021/acsomega.5c05845 YÖKSİS SJR Q1 JCR Q2 OpenAlex 23.5%
  3. 2024 3-Aminobenzamide-linked multifunctional nanoparticles enhances anticancer activity of low-dose cisplatin chemotherapy in lung adenocarcinoma Journal of Drug Delivery Science and Technology DOI 10.1016/j.jddst.2024.106038 YÖKSİS SJR Q1 JCR Q1 OpenAlex 78.6%
  4. 2021 Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy Drug Design, Development and Therapy DOI 10.2147/DDDT.S285852 YÖKSİS SJR Q1 JCR Q2 OpenAlex top 10% OpenAlex 95.4%
  5. 2019 The Role of Cysteine Cathepsins in Cancer Progression and Drug Resistance International Journal of Molecular Sciences DOI 10.3390/ijms20143602 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 96.4%
  6. 2019 İnsan Kolon Kanseri Hücrelerine Karşı İnorganik Nanopartikül-Temelli İlaç Taşıyıcı Sistemlerin Kullanılması: Partikül Büyüklüğünün Antikanser Aktivitesine Etkisi Journal of Polytechnic DOI 10.2339/politeknik.496351 YÖKSİS JCR Q4 OpenAlex 0.9%
  7. 2019 Pasif Tümör Hedefli İnorganik İlaç Nanotaşıyıcıların Akciğer Sağlıklı ve Kanser Hücreleri Üzerindeki Uzun Dönemli Etkisi Journal of Polytechnic DOI 10.2339/politeknik.496354 YÖKSİS JCR Q4 OpenAlex 41.3%
  8. 2019 Cascade therapy with doxorubicin and survivin-targeted tailored nanoparticles: An effective alternative for sensitization of cancer cells to chemotherapy International Journal of Pharmaceutics DOI 10.1016/j.ijpharm.2019.02.036 YÖKSİS SJR Q1 JCR Q1 OpenAlex 61.9%
  9. 2018 Environmentally Responsive Dual-Targeting Nanoparticles: Improving Drug Accumulation in Cancer Cells as a Way of Preventing Anticancer Drug Efflux Journal of Pharmaceutical Sciences DOI 10.1016/j.xphs.2017.10.029 YÖKSİS SJR Q1 JCR Q2 OpenAlex 58.4%
  10. 2018 İlaç Taşıma Sistemleri olarak Nanopartiküller kullanılarak Pasif ve Aktif Tümör Hedeflemelerinin Karşılaştırmalı İncelenmesi Academic Platform-Journal of Engineering and Science DOI 10.21541/apjes.349889 YÖKSİS TR Index OpenAlex 45.3%
  11. 2017 Enhancing Tumor Cell Response to Multidrug Resistance with pH-Sensitive Quercetin and Doxorubicin Conjugated Multifunctional Nanoparticles Colloids and Surfaces B: Biointerfaces DOI 10.1016/j.colsurfb.2017.05.012 YÖKSİS SJR Q1 JCR Q1 OpenAlex 86.0%
  12. 2017 Cloning, expression, and activity analysis of human cathepsin C in the yeast Pichia pastoris TURKISH JOURNAL OF BIOLOGY DOI 10.3906/biy-1704-4 YÖKSİS TR Index SJR Q2 JCR Q4 OpenAlex 53.8%
  13. 2017 Therapeutic Effects of AICAR and DOX Conjugated Multifunctional Nanoparticles in Sensitization and Elimination of Cancer Cells via Survivin Targeting Pharmaceutical Research DOI 10.1007/s11095-016-2053-7 YÖKSİS SJR Q1 JCR Q2 OpenAlex 73.5%
  14. 2016 Synthesis and Characterization of AICAR and DOX Conjugated Multifunctional Nanoparticles as a Platform for Synergistic Inhibition of Cancer Cell Growth Bioconjugate Chemistry DOI 10.1021/acs.bioconjchem.6b00080 YÖKSİS SJR Q1 JCR Q1 OpenAlex 80.0%
  15. 2012 Covalent immobilization of trypsin on glutaraldehyde activated silica for protein fragmentation Artificial Cells, Blood Substitutes, and Biotechnology DOI 10.3109/10731199.2012.686917 YÖKSİS JCR Q4 OpenAlex 63.6%

Projects 7 See all (7) →

  1. 2021 Kitosan Temelli Teranostik Nanopartiküllerin Sentezi ve Karakterizasyonu Yükseköğretim Kurumları tarafından destekli bilimsel araştırma projesi · Tamamlandı 2021-04-01 – 2022-06-01
  2. 2020 İlaç Nanotaşıyıcılarının Sağlıklı Hücreler Üzerindeki Uzun Dönemli Etkileri Yükseköğretim Kurumları tarafından destekli bilimsel araştırma projesi · Tamamlandı 2020-06-15 – 2021-07-01
  3. 2019 Sisplatin Kemoterapisi için Çeşitli Kanser Hücrelerinin DNA Onarım Mekanizmasını İnhibe Ederek Anti-Kanser Potansiyellerinin Artırılması Yükseköğretim Kurumları tarafından destekli bilimsel araştırma projesi · Tamamlandı 2019-10-07 – 2021-07-01
  4. 2016 Kanser hücrelerinde antikanser ilaç birikimini arttırmak için çevre duyarlı ve çoklu hedeflemeli multifonksiyonel nanopartiküllerin sentezi, karakterizasyonu ve terapötik potansiyellerinin araştırılması İZMİR YÜKSEK TEKNOLOJİ ENSTİTÜSÜ ARAŞTIRMA PROJESİ · Tamamlandı 2016-01-01 – 2017-01-01
  5. 2015 Tümör hücrelerinin kemoterapi’ye karşı hassaslaştırılması amacıyla çoklu ilaç direncine karşı pH-duyarlı multifonksiyonel nanopartiküllerin sentezi ve terapötik etkinliklerinin araştırılması İZMİR YÜKSEK TEKNOLOJİ ENSTİTÜSÜ ARAŞTIRMA PROJESİ · Tamamlandı 2015-07-01 – 2016-07-01

Books 1

  1. 2023 A Guide to Vitamins and Their Effects on Diseases Cambridge Scholars Publishing ISBN 1-5275-0092-6 Kitap Bölümü · Bilimsel Kitap

Proceedings 15 See all (15) →

  1. 2022 A future strategy for cancer care: Overcoming cancer drug resistance by designing nanodrug formulations Young Scientists’ School in Molecular Pharmacology
  2. 2017 Fabrication and Characterization of Multifunctional Nanoparticles for pH-sensitive Anticancer Drug Delivery 2. International Mediterranean Science and Engineering Congress
  3. — Therapeutic Effects of Combination Therapy with 3AB and Low Dose Cisplatin on Cervical Cancer Cells 7th Symposium on EuroAsian Biodiversity (SEAB) - 2024
  4. 2020 Gelecekteki Bir Strateji Olarak Kanser Tedavisinde Biyonanomalzemeler 2. International Congress of Updates inBiomedical Engineering
  5. 2011 Covalent Immobilization of Trypsin on Glutaraldehyde Activated Silica for Protein Fragmantation The International Conference on Enzyme Science and Technology

← Back to academicians

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
15
With an akaturk profile
4
Turkish institutions
3
Co-authored works
%67

Academic co-authors 4

  1. BURCU OKUTUCU PAZARLI Profesör · Ege Üniversitesi 2
  2. ARZU GÖRMEZ Profesör · Dokuz Eylül Üniversitesi 1
  3. FİGEN ZİHNİOĞLU Profesör · Ege Üniversitesi 1
  4. YUSUF TUTAR Profesör · Recep Tayyip Erdoğan Üniversitesi 1

National collaboration 3 institutions

  1. Ege Üniversitesi 3 works · 2 academics
  2. Dokuz Eylül Üniversitesi 1 works · 1 academics
  3. Recep Tayyip Erdoğan Üniversitesi 1 works · 1 academics

Other co-authors (incl. international) 11

FATMA NECMİYE KACI 6Magdalena Rudzinska 2AA Zamyatnin JrAlessandro ParodiAndrey O MorozovAndrey Z VinarovAndrey ZamyatninDmitry O KorolevLV SavvateevaR AntoineSurinder M Soond

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.